TRACK 1: Optimizing Clinical Trials : Third Annual clinical biomarkers
Grand Hyatt Washington
1000 H Street NW
Washington, DC
TRACK 1: Optimizing Clinical Trials : Third Annual clinical biomarkers
Cambridge Healthtech Institute  

Schedule of Presentations:

Thursday, September 24, 2009
11:00:00 Technology Showcase: Clinical Biomarkers
11:30:00 Sponsored Presentations (Opportunities Available)
12:30:00 Lunch on your own
13:55:00 Plenary Keynotes
14:00:00 Use of Biomarkers and Translational Science to Accelerate and Improve Oncology Drug Development: Opportunities and Roadblocks J. Carl Barrett
14:30:00 Enabling Personalized Medicine through Application of Biomarkers in Clinical Development Nicholas C. Dracopoli
15:00:00 Networking Refreshment Break with Poster and Exhibit Viewing
16:00:00 Drug/Diagnostic Co-Development (Shared Session with Targeted Therapy meeting)
16:00:00 The Potential Impact of Recently Approved and Emerging Molecular Diagnostics in Drug-Diagnostics Co-Development Francis Kalush
16:30:00 Biomarkers - Driven Drug and Diagnostic Co-Development in Oncology: Current Trends and Future Approaches Miro Venturi
17:00:00 Challenges of Integrating Targeted Biomarker Tests into Clinical Practice Walter Carney
17:30:00 Close of Day
Friday, September 25, 2009
07:30:00 Breakfast Presentations (Opportunities Available)
08:15:00 Incorporating Biomarkers into Clinical Trials
08:25:00 Chairperson’s Opening Remarks
08:30:00 From Science to Solutions: New Paradigms in Biomarker Research Carol J. McCall
09:00:00 Clinical Biomarkers for Osteoarthritis Nextgen logo Bryan Krastins
09:30:00 Using Proteomics and Established Patient Cohorts to Address Relevant Clinical Biomarker Needs: The MURDOCK Study J. Will Thompson
10:00:00 Networking Coffee Break
10:30:00 Translational Medicine’s Role in Target Validation and Patient Selection in Oncology Drug Development Giora Feuerstein
10:30:00 Biomarkers for Patient Selection (Shared Session with Targeted Therapy meeting)
11:00:00 Predictive Markers for Optimizing Selection of Colorectal Cancer Patients for Treatment with ERBITUX® (Cetuximab) Shirin Khambata-Ford
11:30:00 Oncology Biomarkers and Response to Therapy Jill M. Kolesar
12:00:00 Close of Congress
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.